Categories

Retinoid skincare

"Retinoid" is the chemical family of vitamin A and its derivatives. In Europe, some retinoids are cosmetic ingredients, used at concentrations capped under Annex III of the Cosmetic Regulation; others are medicinal active substances reserved to the pharmacy channel.

The retinoid family

The retinoid family comprises a series of structurally related molecules that interact, directly or after metabolic activation, with nuclear retinoic-acid receptors. The principal members are:

• Retinol — vitamin A alcohol. Cosmetic ingredient, restricted under Annex III of Regulation 1223/2009.
• Retinaldehyde (INCI: Retinal) — one step closer to active retinoic acid than retinol. Cosmetic ingredient.
• Retinyl esters — Retinyl Palmitate, Retinyl Acetate, Retinyl Linoleate. Storage forms; cosmetic ingredients, with Annex III conditions for retinyl acetate and retinyl palmitate following SCCS opinion.
• Tretinoin (all-trans retinoic acid) — prescription medicinal substance, not used in cosmetics.
• Isotretinoin (13-cis retinoic acid) — oral and topical prescription medicines, not cosmetic ingredients.
• Adapalene — synthetic third-generation retinoid; medicinal substance, with variable prescription status by jurisdiction (in some EU Member States certain formulations are available over the counter in pharmacies, in others by prescription).
• Tazarotene, trifarotene — synthetic medicinal retinoids, prescription only.

The regulatory boundary

The boundary between cosmetic and medicinal retinoids is set by the EU definition of a medicinal product (Directive 2001/83/EC), interpreted product by product. In broad terms:

• Retinol, retinaldehyde and retinyl esters used in finished cosmetic products at the concentrations and conditions permitted by Annex III of Regulation (EC) No 1223/2009, and presented for cosmetic functions, are cosmetic ingredients.
• Tretinoin and other prescription retinoids in topical preparations are medicinal products and are not within cosmetic law. They are reserved to the pharmacy channel under national rules and require a prescription where the national classification so requires.

The cosmetic concentration limits adopted under Annex III for retinol and retinyl esters reflect SCCS assessments of cumulative exposure to vitamin A from cosmetics in light of dietary intake. The current consolidated text on EUR-Lex is the operational reference for the applicable numerical limits and any required label warnings.

Cosmetic use considerations

Cosmetic retinoid products are positioned for textural and tone-related concerns. The use experience commonly includes a "retinisation" period of mild irritation, dryness and erythema in the early weeks of regular use, particularly with higher-strength retinol formulations. Many product instructions recommend evening application and the use of daytime sun protection. None of this constitutes treatment of a disease and any product that presents itself as treating a disease re-classifies as a medicinal product.

For consumers

For label literacy, the INCI list will identify any cosmetic retinoid by its INCI name (Retinol, Retinal, Retinyl Palmitate, etc.). The concentration is not generally declared on the label; many brands publish concentrations in product literature. A product describing itself as containing a "retinoid" should be examinable on the basis of its INCI list. Prescription topical retinoids — tretinoin, adapalene where prescription-only — will only be available through the pharmacy channel and after a clinical interaction; they are not sold in parapharmacies in France, Spain or Belgium, and are not within the scope of self-selection in any EU Member State without the relevant prescription.

This site does not provide treatment advice. For questions on the management of a specific skin condition such as acne or photo-ageing, the appropriate advice is from a pharmacist or a physician (dermatologist).

Last reviewed: May 2026.